穿皮冠状动脉干预期间冠状动脉剖析的发生率,治疗和结果
Elizabeth Page, Spyridon Kostantinis, Judit Karacsonyi
1Director of the Center for Complex Coronary Interventions, Minneapolis Heart Institute, Chairman of the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation, 920 E 28th Street #300, Minneapolis, Minnesota 55407. esbrilakis@gmail.com.
The Journal of invasive cardiology
|September 28, 2023
概括
冠状动脉剖析是皮肤穿透冠状动脉干预 (PCI) 的并发症,不经常发生,但具有重大风险. 本研究详细介绍了其特征和不良结果,包括死亡和心肌梗塞.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
背景情况:
- 冠状动脉解剖是穿皮冠状动脉干预 (PCI) 的严重并发症.
- 了解其发生率,原因和结果对于患者管理至关重要.
研究的目的:
- 分析与PCI后冠状动脉剖析相关的临床,血管学和程序因素.
- 评估冠状动脉剖析的结果和并发症.
主要方法:
- 在2014年至2019年期间进行的10,278个PCI的回顾性分析.
- 检查了患者的人口统计,血管特征,剖析原因,治疗策略和临床结果.
- 评估住院和长期不良事件,包括死亡率和目标病变再血管化.
主要成果:
- 无计划的冠状动脉剖析发生在1.4%的PCI中.
- 导线推进是最常见的原因 (30%),其次是支架 (22%).
- 住院主要不良心血管事件为23%,包括7%的死亡率和9%的急性心肌梗塞;长期死亡率为20%.
结论:
- 冠状动脉剖析是PCI的一种罕见但显著的并发症.
- 它与显著的不良临床结果有关,包括增加死亡率和心肌梗塞.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Cardiac Catheterization I: Pre-Procedure Overview
47
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
47
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30


